These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12649411)

  • 21. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
    Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analisis of the budget impact of adalimumab and etanercept in rheumatoid arthritis and spondyloarthropathies].
    González Álvarez A; Gómez Barrera M; Borrás Blasco J; Giner Serret EJ
    Farm Hosp; 2013; 37(3):192-7. PubMed ID: 23789797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept-associated injection-site reactions.
    Murphy FT; Enzenauer RJ; Battafarano DF; David-Bajar K
    Arch Dermatol; 2000 Apr; 136(4):556-7. PubMed ID: 10768663
    [No Abstract]   [Full Text] [Related]  

  • 25. Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Klingman D; Hazard E; Ray S
    Clin Ther; 2009 Apr; 31(4):825-35. PubMed ID: 19446156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice.
    Moots RJ; Haraoui B; Matucci-Cerinic M; van Riel PL; Kekow J; Schaeverbeke T; Davis A; Tedeschi MA; Freundlich B; Chang DJ; Singh A
    Clin Exp Rheumatol; 2011; 29(1):26-34. PubMed ID: 21345289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of pseudogout during etanercept treatment.
    Josefina M; Ana CJ; Ariel V; Silvio AA
    J Clin Rheumatol; 2007 Jun; 13(3):177. PubMed ID: 17551392
    [No Abstract]   [Full Text] [Related]  

  • 28. Discontinuation of etanercept in patients with rheumatoid arthritis who were in clinical remission.
    Miyamura T; Sonomoto K; Nakamura M; Horai Y; Takahama S; Ando H; Minami R; Yamamoto M; Suematsu E
    Clin Rheumatol; 2010 Jan; 29(1):87-90. PubMed ID: 19756835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate.
    Harley CR; Frytak JR; Tandon N
    Am J Manag Care; 2003 Oct; 9(6 Suppl):S136-43. PubMed ID: 14577718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha].
    Brocq O; Plubel Y; Breuil V; Grisot C; Flory P; Mousnier A; Euller-Ziegler L
    Presse Med; 2002 Nov; 31(39 Pt 1):1836-9. PubMed ID: 12496713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and longstanding rheumatoid arthritis.
    Weinblatt ME; Bathon JM; Kremer JM; Fleischmann RM; Schiff MH; Martin RW; Baumgartner SW; Park GS; Mancini EL; Genovese MC
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):373-82. PubMed ID: 20957659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME; Schiff MH; Ruderman EM; Bingham CO; Li J; Louie J; Furst DE
    Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COMET's path, and the new biologicals in rheumatoid arthritis.
    Kremer JM
    Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutropenia after the third cycle of etanercept: could it be due to immunogenicity?
    Olsen NJ; Elmagboul N
    J Clin Rheumatol; 2014 Jun; 20(4):237-8. PubMed ID: 24847756
    [No Abstract]   [Full Text] [Related]  

  • 35. Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart audit.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Cohen MD
    J Manag Care Pharm; 2004; 10(6):538-42. PubMed ID: 15548126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plans.
    Joyce AT; Gandra SR; Fox KM; Smith TW; Pill MW
    J Med Econ; 2014 Jan; 17(1):1-10. PubMed ID: 24131136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Case of successful pregnancy and childbirth in a rheumatoid arthritis patient treated with etanercept].
    Furukawa K; Maeshima E; Ichinose M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(1):47-51. PubMed ID: 23445732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adverse events in rheumatoid arthritis patient with etanercept therapy: the appearance of osteomalacia].
    D'Amore M; Minenna G; D'Amore S
    Recenti Prog Med; 2005 Nov; 96(11):552-5. PubMed ID: 16499162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.